Orange Book product · Brand (NDA)
PROMACTA KIT
ELTROMBOPAG OLAMINE
At a glance
Sep 27, 2018
Approved
Brand (NDA)
Application
AB
TE code
5
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Sep 27, 2018
7 yr 10 mo ago
Patent 7547719 expires
Listed drug substance patent expiration.
Jul 13, 2025
11 mo ago
Patent 7547719 expires
Listed drug substance patent expiration.
Jul 13, 2025
11 mo ago
Patent 7547719 expires
Listed drug substance patent expiration.
Jul 13, 2025
11 mo ago
Patent 7547719 expires
Listed drug substance patent expiration.
Jul 13, 2025
11 mo ago
Patent 7547719*PED expires
Listed listed patent expiration.
Jan 13, 2026
5 mo ago
Today
Pharmaceutical detail
Active ingredient
ELTROMBOPAG OLAMINE
Strength
EQ 12.5MG ACID/PACKET
Dosage form
FOR SUSPENSION
Route
ORAL
TE code
AB
Application
NDA 207027
Product number
002
Marketing status
RX
Reference listed drug (RLD)
Yes
Reference standard (RS)
No
Active-ingredient family
View full familyThis is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.
- 2011PROMACTABrand (NDA)
NDA 022291 · NOVARTIS
- 2026ELTROMBOPAG OLAMINEGeneric (ANDA)
ANDA 220660 · BIOCON PHARMA
- 2026ELTROMBOPAG OLAMINEGeneric (ANDA)
ANDA 220033 · HIKMA
- 2026ELTROMBOPAG OLAMINEGeneric (ANDA)
ANDA 219121 · DR REDDYS
- 2026ELTROMBOPAG OLAMINEGeneric (ANDA)
ANDA 212884 · AMNEAL
- 2026ELTROMBOPAG OLAMINEGeneric (ANDA)
ANDA 220250 · MSN
- 2026ELTROMBOPAG OLAMINEGeneric (ANDA)
ANDA 219638 · SOMERSET THERAPS LLC
- 2026ELTROMBOPAG OLAMINEGeneric (ANDA)
ANDA 216281 · ZYDUS PHARMS
- 2025ELTROMBOPAG OLAMINEGeneric (ANDA)
ANDA 206788 · HETERO LABS LTD V
- 2024ELTROMBOPAG OLAMINEGeneric (ANDA)
ANDA 216620 · ANNORA PHARMA
Listed patents (5)
| Patent | Expires | In | Type |
|---|---|---|---|
| 7547719 | Jul 13, 2025 | 11 mo ago | SubstanceProductU-2452 |
| 7547719 | Jul 13, 2025 | 11 mo ago | SubstanceProductU-1736 |
| 7547719 | Jul 13, 2025 | 11 mo ago | SubstanceProductU-1575 |
| 7547719 | Jul 13, 2025 | 11 mo ago | SubstanceProductU-1306 |
| 7547719*PED | Jan 13, 2026 | 5 mo ago |

